Groupe Hospitalier Saint André - Hôpital Saint André

Bordeaux 33075

0 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Merkel Cell, Malignant Melanoma, Melanoma, Metastatic Colorectal Cancer

Studies at this site

• A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma — Completed
• Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200) — Completed
• A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma — Completed
• A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma — Completed
• Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer — Completed